Literature DB >> 22592153

Dermatology life quality index (DLQI): a paradigm shift to patient-centered outcomes.

Andrew Y Finlay1, Mohammad K A Basra2, Vincent Piguet2, M Sam Salek3.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22592153     DOI: 10.1038/jid.2012.147

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  11 in total

1.  Discrepancies between the Dermatology Life Quality Index and utility scores.

Authors:  Fanni Rencz; Petra Baji; László Gulácsi; Sarolta Kárpáti; Márta Péntek; Adrienn Katalin Poór; Valentin Brodszky
Journal:  Qual Life Res       Date:  2015-12-18       Impact factor: 4.147

Review 2.  A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies.

Authors:  Alexandre Chan; Michael C Cameron; Benjamin Garden; Christine B Boers-Doets; Katja Schindler; Joel B Epstein; Jennifer Choi; Laura Beamer; Eric Roeland; Elvio G Russi; René-Jean Bensadoun; Yi Ling Teo; Raymond J Chan; Vivianne Shih; Jane Bryce; Judith Raber-Durlacher; Peter Arne Gerber; César O Freytes; Bernardo Rapoport; Nicole LeBoeuf; Vincent Sibaud; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2015-01-07       Impact factor: 3.603

3.  [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany].

Authors:  E Haufe; S Abraham; A Heratizadeh; I Harder; A Zink; E Weisshaar; A Kleinheinz; R von Kiedrowski; M Worm; M Bell; A Wollenberg; K Neubert; P Staubach-Renz; M Hilgers; T Bieber; I Fell; B Homey; I Effendy; M Mempel; K Schäkel; S Beissert; S Weidinger; T Werfel; J Schmitt
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

4.  Correlates of self-reported quality of life in adults and children with morphea.

Authors:  Shinjita Das; Ira Bernstein; Heidi Jacobe
Journal:  J Am Acad Dermatol       Date:  2014-02-16       Impact factor: 11.527

5.  Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer.

Authors:  Johannes Wohlrab; Nikola Bangemann; Anke Kleine-Tebbe; Marc Thill; Sherko Kümmel; Eva-Maria Grischke; Rainer Richter; Sophie Seite; Diana Lüftner
Journal:  Breast Cancer (Dove Med Press)       Date:  2014-08-01

6.  Comparison of Treatment Goals for Moderate-to-Severe Psoriasis between Korean Dermatologists and the European Consensus Report.

Authors:  Sang Woong Youn; Bo Ri Kim; Joo Heung Lee; Hae Jun Song; Yong Beom Choe; Ji Ho Choi; Nack In Kim; Kwang Joong Kim; Jai Il Youn
Journal:  Ann Dermatol       Date:  2015-03-24       Impact factor: 1.444

7.  The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional Study.

Authors:  Jaewon Lee; Jin Lim; Jong Seo Park; Miso Kim; Tae-Yong Kim; Tae Min Kim; Kyung-Hun Lee; Bhumsuk Keam; Sae-Won Han; Je-Ho Mun; Kwang Hyun Cho; Seong Jin Jo
Journal:  Cancer Res Treat       Date:  2017-12-14       Impact factor: 4.679

Review 8.  Counting the Burden: Atopic Dermatitis and Health-related Quality of Life.

Authors:  Faraz Ali; Jui Vyas; Andrew Y Finlay
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

9.  Quality of life profile and correlated factors in chronic leg ulcer patients in the mid-west of São Paulo State, Brazil.

Authors:  Patrick Alexander Wachholz; Paula Yoshiko Masuda; Dejair Caitano Nascimento; Cecilia Midori Higashi Taira; Norma Gondim Cleto
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

10.  Assessing Changes in Chronic Spontaneous/Idiopathic Urticaria: Comparisons of Patient-Reported Outcomes Using Latent Growth Modeling.

Authors:  Donald E Stull; Doreen McBride; Katherine Houghton; Andrew Y Finlay; Ari Gnanasakthy; Maria-Magdalena Balp
Journal:  Adv Ther       Date:  2016-01-30       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.